Dermatomyositis and polymyositis (myositis) trials in Serbia

3 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Not yet taking people in Serbia
  A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies

  Where

  Belgrade, Kragujevac

  Age

  18 years and over

  People

  270 worldwide

  Run by

  Boehringer Ingelheim

  See details and how to joinNCT07789015 · EU 2026-526365-24-00
• Phase 3Enrolling by invitation
  A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

  Where

  Belgrade

  Age

  18 years and over

  People

  240 worldwide

  Run by

  argenx

  See details and how to joinNCT05979441 · EU 2022-502851-79-00
• Phase 2Taking people
  AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  Where

  Belgrade

  Age

  18 years and over

  People

  90 worldwide

  Run by

  Artiva Biotherapeutics, Inc.

  See details and how to joinNCT06991114 · EU 2025-520461-41-00